• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Weekly Roundup: October 5-9


ICYMI, some of the content featured this week includes articles about abobotulinumtoxinA injections for oily forehead, promising therapies for blastic plasmacytoid dendritic cell neoplasm (BPDCN), the benefits of CBD for the skin, plus more.

In case you missed it, some of this week’s featured content includes articles about a new scalpel that increases wound healing, Allergan Aesthetics announces a new brand identity, the benefits of CBD for the skin, abobotulinumtoxinA injections to treat an oily forehead, promising therapies for blastic plasmacytoid dendritic cell neoplasm (BPDCN), plus a new episode of our podcast, The Cutaneous Connection, that discusses how to build your brand as a physician.

POLL: Did you use telemedicine before or after the start of the pandemic?

Tagraxofusp treatment for BPDCN continues to evolve

A recent paper details the different ways scientists are investigating tagraxofusp to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare hematologic malignancy that often presents with skin manifestations.

The Mainstream Patient: October 5

This week’s edition of The Mainstream Patient features stories about snail slime in skincare, how to treat hyperpigmentation, different exfoliation methods, maskne during the fall, plus more.

Allergan Aesthetics launches new brand identity

Aesthetic medicine company, Allergan Aesthetics, launches a new brand identity focused on empowering confidence and promoting diversity.

CD123-targeted therapies promising in BPDCN and AML

Several CD123-targeted therapies have been in development following the FDA’s 2018 approval of tagraxofusp for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN), but important questions remain when it comes to targeting CD123 in myeloid malignancies.

New scalpel increases wound healing

Entrepix Medical, LLC, launches their new Planatome blade, which has shown in multiple studies to increase wound closure, reduce tissue trauma and strength the wound.

The Cutaneous Connection: Episode 8- Building Your Brand as a Physician

Media expert Paige Velasquez Budde, CEO of Zilker Media, explains the importance of building a brand as a physician, as well as some mistakes to avoid and tips on how to grow and shape your brand.

Does CBD benefit the skin?

The use of CBD skincare products is recently on the rise, but do these products really possess the skin benefits companies claim they do?

AbobotulinumtoxinA for oily forehead

Dr. Katarina Kesty, St. Petersburg Skin and Laser, St. Petersburg, Fla., discusses her presentation at the 2020 virtual American Society for Dermatologic Surgery (ASDS) meeting about her research using abobotulinumtoxinA injections to combat oil on the forehead.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.